Cargando…
SARS-CoV-2 Spike Protein-Expressing Enterococcus for Oral Vaccination: Immunogenicity and Protection
The declaration of the conclusion of the COVID-19 pandemic notwithstanding, coronavirus remains prevalent in circulation, and the potential emergence of novel variants of concern introduces the possibility of new outbreaks. Moreover, it is not clear how quickly and to what extent the effectiveness o...
Autores principales: | Suvorov, Alexander, Loginova, Svetlana, Leontieva, Galina, Gupalova, Tatiana, Desheva, Yulia, Korzhevskii, Dmitry, Kramskaya, Tatiana, Bormotova, Elena, Koroleva, Irina, Kopteva, Olga, Kirik, Olga, Shchukina, Veronika, Savenko, Sergey, Kutaev, Dmitry, Borisevitch, Sergey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675790/ https://www.ncbi.nlm.nih.gov/pubmed/38006046 http://dx.doi.org/10.3390/vaccines11111714 |
Ejemplares similares
-
Construction of the Enterococcal Strain Expressing Immunogenic Fragment of SARS-Cov-2 Virus
por: Suvorov, Alexander, et al.
Publicado: (2022) -
Developing a Live Probiotic Vaccine Based on the Enterococcus faecium L3 Strain Expressing Influenza Neuraminidase
por: Desheva, Yulia, et al.
Publicado: (2021) -
A Live Probiotic Vaccine Prototype Based on Conserved Influenza a Virus Antigens Protect Mice against Lethal Influenza Virus Infection
por: Mezhenskaya, Daria, et al.
Publicado: (2021) -
Development of experimental GBS vaccine for mucosal immunization
por: Gupalova, T., et al.
Publicado: (2018) -
Pilot Study Results on Antibodies to the S- and N-Proteins of SARS-CoV-2 in Paired Sera from COVID-19 Patients with Varying Severity
por: Desheva, Yulia, et al.
Publicado: (2023)